FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and immunology and represents a recombinant protein containing an antigenically significant protein fragment of hepatitis E 1 genotype, used in test systems for serodiagnosis of hepatitis E (embodiments).
EFFECT: invention increases accuracy of results in test systems by reducing false-positive results.
4 cl, 3 dwg, 1 tbl
Authors
Dates
2020-01-23—Published
2017-12-22—Filed